HOME >> MEDICINE >> NEWS
Novel molecule blocks pain receptor system

Discovery May Lead to New Treatments for Pain

Researchers with Banyu Pharmaceutical Co. in Japan have designed a synthetic molecule that can block a molecular pathway, allowing researchers a closer look at what makes some people less sensitive to pain.

This finding will appear in the Dec. 16 issue of the peer-reviewed Journal of Medicinal Chemistry, published by the American Chemical Society, the world's largest scientific society. The article was initially published Nov. 19 on the journal's web site.

Scientists have been studying a nerve receptor called the "opiod receptor-like 1" (ORL-1), which is widely distributed throughout the central nervous system. Like other opiod receptors, ORL-1 was believed to play a key role in pain regulation. However, the natural compounds that activate ORL-1 are different than those that activate the opiod receptors, the researchers say.

In 1995, scientists found a novel hormone, called nociceptin or orphanin FQ, that binds to the ORL-1 receptor. They theorized that blocking the hormone may make a person less sensitive to pain. It has been difficult to test this theory because researchers have lacked an agent to block the hormone-receptor system so its functions could be observed and tested.

Now, the Japanese researchers believe they have found that agent. While there are many different ways to prevent pain, this discovery represents a new avenue for pain research and could be key to development of new and improved drugs to treat pain, says Yoshikazu Iwasawa, Ph.D., research director at Banyu Pharmaceutical Co.

Studies in mice suggest that the ORL-1 receptor and its corresponding hormones may also play important roles in anxiety, learning and memory and other neurological responses. Further understanding of the roles of this hormone-receptor system may lead to drugs not just for pain, but for a variety of neurological disorders, Dr. Iwasawa and hi
'"/>

Contact: Beverly Hassell
b_hassell@acs.org
202-872-4065
American Chemical Society
14-Dec-1999


Page: 1 2

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
9. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
10. Novel findings about neovessel formation
11. Novel MRI technique provides clear images of blood flow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/12/2020)... ... 2020 , ... Cecelia Health ( http://www.ceceliahealth.com ), a leading ... for over a decade to transform lives and health outcomes for patients and ... By optimizing the mix of expert clinician and digital touchpoints in clinically tested ...
(Date:1/10/2020)... ... January 10, 2020 , ... Sigma Theta Tau International ... Book of the Year Awards. These awards are regarded as one of the most ... year, the AJN Book of the Year competition has recognized Sigma for the last ...
(Date:1/10/2020)... ... 10, 2020 , ... WellHaven Pet Health, a family of companion animal veterinary ... coming in February 2020, LEAD WELL with WOMEN. The community will be showcased at ... of LEAD WELL with WOMEN is to empower women, engage all, connect, and help ...
(Date:1/10/2020)... ... January 10, 2020 , ... The value of healthy ... is via a preventative approach. Leading eye care doctor, Brent Bellotte MD., champions such ... many common eye diseases. , Eyesight is something that many take for granted until ...
(Date:1/10/2020)... ... January 10, 2020 , ... ... Oregon, provides a friendly, non-intimidating environment for all women. In search for a ... its current and prospective members. , For nearly 30 years, Balanced Habits, ...
Breaking Medicine News(10 mins):
(Date:1/12/2020)... ... 2020 , ... FutuRx, Israel’s leading biopharmaceutical incubator, a partnership ... Inc, operating under a tender from the Israeli Innovation Authority (IIA) has recently ... Tel-Aviv University and Glasgow University. , Epeius pharma develops next generation biological ...
(Date:1/10/2020)... ... January 10, 2020 , ... ... an affiliation agreement that officially brings GCMC into the family of hospitals affiliated ... City provides the network and its patients with a vital new access point ...
(Date:1/10/2020)... ... January 10, 2020 , ... Representatives with MyBioGate announced that they are ... partners conference will be held on 12 January 2020 at the Grand Hyatt ... be your gateway to China’s healthcare and life science industry. For the overseas biopharmas ...
Breaking Medicine Technology:
Cached News: